Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FNGG vs HCMT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HCMT Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

HCMT Overall Winner 6-Pillar Tally: FNGG 0 – 0 HCMT (6 Tie) Matrix Metrics: FNGG 1 – 2 HCMT

As of Nov 16, 2026, Direxion HCM Tactical Enhanced US ETF (HCMT) is the stronger overall head-to-head candidate over Direxion Daily NYSE FANG+ Bull 2X Shares (FNGG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FNGG carries a Unified Composite Score of 50.1/100 (HOLD) at $208.42 (N/M Forward P/E, N/A operating margin), whereas HCMT carries 53.7/100 (HOLD) at $37.60 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: FNGG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.8); meanwhile HCMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FNGG vs HCMT
FNGG NYSE Arca
Direxion Daily NYSE FANG+ Bull 2X Shares
Institutional Equity
$208.42
-6.87% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 3.07β · 68% Vol
Unified Composite Score
50.1 / 100 HOLD
Tech 43.0 Fund 54.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 34
RSI-14: 33.8 · SMA20: $235.05 · SMA50: $258.60
HCMT NYSE Arca Head-to-Head Winner
Direxion HCM Tactical Enhanced US ETF
Institutional Equity
$37.60
-2.12% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.70β · 36% Vol
Unified Composite Score
53.7 / 100 HOLD
Tech 60.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.9%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $39.39 · SMA50: $41.17

6-Pillar Scorecard Institutional Category Breakdown (FNGG 0 – 0 HCMT)

Columns: Metric · FNGG · HCMT
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 41.1% (4th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FNGG (1) vs HCMT (2)
Institutional Metric FNGG HCMT Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
46% ($139–$292) 32% ($34–$45) Stronger Trend FNGG
Beta / 30D Volatility
Risk Regime
3.07β · 68% Vol 1.70β · 36% Vol Lower Realized Risk HCMT
Unified Institutional Score
Composite Signal
50.1 / 100 (HOLD) 53.7 / 100 (HOLD) Higher Composite HCMT
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HCMT +12.28 pp
FNGG: -19.52% · HCMT: -7.24%
3M Horizon HCMT +8.79 pp
FNGG: -17.8% · HCMT: -9.01%
6M Horizon HCMT +4.71 pp
FNGG: -9.65% · HCMT: -4.94%
1Y Horizon HCMT +13.57 pp
FNGG: -14.61% · HCMT: -1.04%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FNGG vs HCMT. Trailing 12-month operating profitability (FNGG N/A vs HCMT N/A) and valuation multiples (FNGG N/M vs HCMT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

FNGG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HCMT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FNGG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 41.1%
IV Percentile 4th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FNGG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HCMT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HCMT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FNGG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HCMT Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ FNGG vs HCMT Key Questions & Quantitative Answers

As of Nov 16, 2026, Direxion HCM Tactical Enhanced US ETF (HCMT) is the stronger overall head-to-head candidate over Direxion Daily NYSE FANG+ Bull 2X Shares (FNGG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). FNGG carries a Unified Composite Score of 50.1/100 (HOLD) at $208.42 (N/M Forward P/E, N/A operating margin), whereas HCMT carries 53.7/100 (HOLD) at $37.60 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: FNGG is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.8); meanwhile HCMT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FNGG and HCMT split Growth & Scale metrics: FNGG posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HCMT at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, FNGG generates N/A in USD-normalized revenue versus N/A for HCMT. In operating R&D and SG&A reinvestment, FNGG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HCMT.

FNGG and HCMT trade at balanced relative valuation multiples. FNGG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HCMT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FNGG (N/A ROE) versus HCMT (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, FNGG carries 41.1% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.07β · 68% Vol realized risk). By comparison, HCMT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.70β · 36% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.